NO20030201L - Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner - Google Patents

Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner

Info

Publication number: NO20030201L
Authority: NO; Norway
Prior art keywords: treatment; viral infections; receptor antagonists; exacerbation; directed
Prior art date: 2000-07-18

Application number

NO20030201A

Other languages

English (en)

Norwegian (no)

Other versions

NO20030201D0 (no

Inventor

Susan B Dillon

Ruth Talsinger

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-18

Filing date

2003-01-15

Publication date

2003-03-17

2003-01-15 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-01-15 Publication of NO20030201D0 publication Critical patent/NO20030201D0/no

2003-03-17 Publication of NO20030201L publication Critical patent/NO20030201L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20030201A 2000-07-18 2003-01-15 Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner NO20030201L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21905300P	2000-07-18	2000-07-18
PCT/US2001/022328 WO2002005814A1 (fr)	2000-07-18	2001-07-16	Utilisation des antagonistes des recepteurs d'il-8 dans le traitement des infections virales

Publications (2)

Publication Number	Publication Date
NO20030201D0 NO20030201D0 (no)	2003-01-15
NO20030201L true NO20030201L (no)	2003-03-17

Family

ID=22817645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030201A NO20030201L (no)	2000-07-18	2003-01-15	Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner

Country Status (17)

Country	Link
EP (1)	EP1307190A4 (fr)
JP (1)	JP2004509852A (fr)
KR (1)	KR20030019587A (fr)
CN (1)	CN1449285A (fr)
AR (1)	AR033830A1 (fr)
AU (1)	AU2001273497A1 (fr)
BR (1)	BR0112603A (fr)
CA (1)	CA2418162A1 (fr)
CZ (1)	CZ2003132A3 (fr)
HU (1)	HUP0300754A3 (fr)
IL (1)	IL153921A0 (fr)
MX (1)	MXPA03000500A (fr)
NO (1)	NO20030201L (fr)
NZ (1)	NZ523659A (fr)
PL (1)	PL365886A1 (fr)
WO (1)	WO2002005814A1 (fr)
ZA (1)	ZA200300474B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2575932A1 (fr) *	2004-08-04	2006-02-16	Schering Corporation	Formulations pharmaceutiques
CR20160529A (es) *	2014-05-12	2017-01-02	Glaxosmithkline Intellectual Property (No 2) Ltd	Composiciones farmacéuticas para tratar enfermedades infecciosas
EP3884932A1 (fr) *	2020-03-26	2021-09-29	Dompe' Farmaceutici S.P.A.	Inhibiteurs de cxcl8 pour leur utilisation dans le traitement de la covid-19
EP4125848A1 (fr) *	2020-03-26	2023-02-08	Dompe' Farmaceutici SpA	Inhibiteurs de cxcl8 destinés à être utilisés dans le traitement de la covid-19
EP4008325A1 (fr) *	2020-12-02	2022-06-08	Dompe' Farmaceutici S.P.A.	Inhibiteurs de cxcl8 pour leur utilisation dans le traitement de la covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5547979A (en) *	1992-03-30	1996-08-20	Smithkline Beecham	TNF inhibition
AU3539795A (en) *	1994-08-25	1996-03-14	Medical University Of South Carolina	Methods of treating cold symptoms using pentoxifylline
EP0809492A4 (fr) *	1995-02-17	2007-01-24	Smithkline Beecham Corp	Antagonistes des recepteurs d'il-8
SE9802729D0 (sv) *	1998-08-13	1998-08-13	Astra Pharma Prod	Novel Compounds
SE9802937D0 (sv) *	1998-09-01	1998-09-01	Astra Pharma Prod	Novel compounds

2001
- 2001-07-16 WO PCT/US2001/022328 patent/WO2002005814A1/fr not_active Ceased
- 2001-07-16 CA CA002418162A patent/CA2418162A1/fr not_active Abandoned
- 2001-07-16 AR ARP010103395A patent/AR033830A1/es not_active Application Discontinuation
- 2001-07-16 AU AU2001273497A patent/AU2001273497A1/en not_active Abandoned
- 2001-07-16 MX MXPA03000500A patent/MXPA03000500A/es unknown
- 2001-07-16 IL IL15392101A patent/IL153921A0/xx unknown
- 2001-07-16 BR BR0112603-2A patent/BR0112603A/pt not_active IP Right Cessation
- 2001-07-16 JP JP2002511746A patent/JP2004509852A/ja not_active Withdrawn
- 2001-07-16 HU HU0300754A patent/HUP0300754A3/hu unknown
- 2001-07-16 KR KR10-2003-7000717A patent/KR20030019587A/ko not_active Withdrawn
- 2001-07-16 NZ NZ523659A patent/NZ523659A/en unknown
- 2001-07-16 CZ CZ2003132A patent/CZ2003132A3/cs unknown
- 2001-07-16 EP EP01952777A patent/EP1307190A4/fr not_active Withdrawn
- 2001-07-16 CN CN01813095A patent/CN1449285A/zh active Pending
- 2001-07-16 PL PL01365886A patent/PL365886A1/xx not_active Application Discontinuation
2003
- 2003-01-15 NO NO20030201A patent/NO20030201L/no not_active Application Discontinuation
- 2003-01-17 ZA ZA200300474A patent/ZA200300474B/en unknown

Also Published As

Publication number	Publication date
HUP0300754A3 (en)	2009-03-02
CZ2003132A3 (cs)	2003-09-17
WO2002005814A1 (fr)	2002-01-24
CN1449285A (zh)	2003-10-15
JP2004509852A (ja)	2004-04-02
KR20030019587A (ko)	2003-03-06
BR0112603A (pt)	2004-08-24
MXPA03000500A (es)	2003-06-24
AU2001273497A1 (en)	2002-01-30
PL365886A1 (en)	2005-01-10
ZA200300474B (en)	2004-08-17
EP1307190A4 (fr)	2007-08-22
NO20030201D0 (no)	2003-01-15
HUP0300754A2 (hu)	2003-08-28
CA2418162A1 (fr)	2002-01-24
AR033830A1 (es)	2004-01-07
NZ523659A (en)	2006-01-27
IL153921A0 (en)	2003-07-31
EP1307190A1 (fr)	2003-05-07

Publication	Publication Date	Title
HUP0400719A2 (hu)	2004-07-28	Vegyületek és eljárások Chlamydia-fertőzés diagnosztikájára és kezelésére
EA200300628A1 (ru)	2003-12-25	Соединения, специфические к аденозиновому a, aи aрецептору, и их применение
BR0110968A (pt)	2005-05-10	Antagonistas dos receptores de il-8
TR200000913T2 (tr)	2001-01-22	Tıbbi maddeler
MA30128B1 (fr)	2009-01-02	Combinaisons pharmaceutiques d'un antagoniste de receptuer d'angiotensine et d'un inhibiteur de nep
FR16C1012I2 (fr)	2019-01-11	Utilisation therapeutique d'anticorps anti-cs1
EA200100780A1 (ru)	2001-12-24	Антагонисты tweak и рецептора tweak и их использование для лечения иммунологических заболеваний
PT951282E (pt)	2008-06-09	Prevenção e tratamento de doenças esqueléticas com agonistas e2 de protaglandinas selectivos do subtipo de receptores ep2
ATE425253T1 (de)	2009-03-15	Tribonektine
ID29095A (id)	2001-07-26	Antagonis mglur5 untuk pengobatan rasa sakit dan kegelisahan
DE60230722D1 (de)	2009-02-26	Il-8-rezeptor-antagonisten
TR199900318T2 (xx)	1999-05-21	IL-8 resept�r antagonistleri.
IS2259B (is)	2007-06-15	Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
DZ3209A1 (fr)	2001-01-11	Antagonistes selectifs du recepteur iGLuR5 utilises dans le traitement de la migraine.
FR2815541B1 (fr)	2008-02-29	Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
PT1252150E (pt)	2003-09-30	Derivados de azois condensados e sua utilizacao como agentes hipoglicemiantes
ATE356994T1 (de)	2007-04-15	Screeningverfahren mit pim1-kinase oder pim3- kinase
EA200400399A1 (ru)	2004-08-26	Способы лечения легочных заболеваний
NO20030201L (no)	2003-03-17	Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner
DE60101559D1 (de)	2004-01-29	Benutzung von comt-inhibitoren als analgetika
IS6426A (is)	2002-06-18	Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni
EE200200517A (et)	2004-02-16	Monoklonaalne antikeha, selle valmistamine ning kasutamine inimese madala tihedusega lipoproteiinide retseptori (LDLR) tuvastamiseks ja puhastamiseks
UY28017A1 (es)	2004-04-30	Tratamiento terapéutico
TR200103448T2 (tr)	2002-06-21	IL-8 reseptör antagonistleri.
DK1421377T3 (da)	2006-08-28	Naturlig ligand for den orphane G-proteinkoblede receptor GPR86 og metoder til anvendelse

Legal Events

Date	Code	Title	Description
2009-02-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application